By Inga Orozco and Kristin Orrell Life sciences companies operate at the leading edge of innovation, structuring high-value licensing, development, and outsourcing arrangements in a highly regulated environment. A persistent and often underappreciated financial reporting risk arises not in the laboratory but at the intersection of contract drafting and accounting interpretation.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Kristin
Contact Kristin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack